BB's Stock Haven

[TradingGems]

$VDRM .0023 THE BEST\HIGHEST POTENTIAL PENNY STOCK IN THE COUNTRY SMART MONEY WE CAN DO THIS!!

VDRM COULD BE THE pharmacy stock of the year. This stock can run 30,000% here's why

1) EXTREMELY OVERSOLD and unknown

2) The TINIEST FLOAT VS PRICE out of ALL pharmacy stocks in the whole country) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. http://www.viadermalicensing.com/

4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.

5) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION! http://www.otcmarkets.com/financialReportViewer?symbol=VDRM&id=145128

6) WON AWARD FOR THEIR DRUG. This drug is amazing http://www.viadermalicensing.com/img/ViaDermaCaseStudies.pdf

7) STRONG HANDS HOLDING 17 million shares out of the TINY 18 million float. (although I think the float is really around 30 million)

8) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.

9) THEY HAVE A PATENT which big boys have to be eyeing.

10) HUGE FILING BACK TO BACK JUST OUT AFTER MONTHS OF SILENCE. REVENUES!!!! Not only that they went from NEGATIVE $6 MILLION year ending 2014 from previous company's convertible debt which they inherited from merger to POSITIVE 27K!!! THATS A $6 MILLION TURNAROUND IN 1 YEAR!!!!!

THE CEO is a great scientist, but horrible marketer. That's where the shareholders show up. time to get the word out for this gem

VDRM IS A HIDDEN GOLDMINE

Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.
Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity.
Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.
Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.
Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher.
VDRM transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City
Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy